Erythropoietin Dose and Mortality in Hemodialysis Patients: Marginal Structural Model to Examine Causality

It has been previously reported that a higher erythropoiesis stimulating agent (ESA) dose in hemodialysis patients is associated with adverse outcomes including mortality; however the causal relationship between ESA and mortality is still hotly debated. We hypothesize ESA dose indeed exhibits a dire...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Int J Nephrol
Autors principals: Streja, Elani, Park, Jongha, Chan, Ting-Yan, Lee, Janet, Soohoo, Melissa, Rhee, Connie M., Arah, Onyebuchi A., Kalantar-Zadeh, Kamyar
Format: Artigo
Idioma:Inglês
Publicat: Hindawi Publishing Corporation 2016
Matèries:
Research Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4889858/
https://ncbi.nlm.nih.gov/pubmed/27298736
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2016/6087134
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars